Toggle Offcanvas
...
 
Global Germany Pharmaceuticals Tenders

Germany Pharmaceuticals Tenders

Latest Germany Pharmaceuticals tenders. Discover new opportunities for Pharmaceuticals tenders daily and win lucrative contracts across Germany.

How big is the Pharmaceuticals market in Germany?

Germany's pharmaceutical market is a heavyweight contender, flexing its muscles with a staggering €50.2 billion annual spend. That's more than just big bucks - it translates to roughly 450,000 highly skilled jobs and a constant hum of innovation. No wonder it's dubbed the "pharmacy of the world."
Germany makes up a cool 4% of global pharma production, churning out meds that keep the world healthy. And with a projected 2.3% growth rate by 2028, it's only set to get bigger.

German government Pharmaceuticals Procurement

The German government is a big pharma spender, contributing a significant chunk of that €50.2 billion. In 2021, they dished out a cool €15.6 billion, supporting research, development, and essential drugs for the public.

What Pharmaceuticals does the German government buy?

The government's shopping list is long and varied, including:
Prescription drugs: From cancer treatments to insulin, the government ensures everyone has access to life-saving meds.
Hospital supplies: Bandages, syringes, and high-tech equipment keep German hospitals running smoothly.
Vaccines: Keeping the population immunized is a top priority, with the government investing heavily in vaccination programs.
Research and development: Supporting the next generation of drugs is crucial, so the government funds innovative research projects.

Major Pharmaceuticals buyers in German government

Several key players call the shots:
Federal Joint Committee (G-BA): This big kahuna evaluates drug safety, efficacy, and cost-effectiveness before they hit the market.
Federal Ministry of Health (BMG): They set the overall healthcare agenda and ensure access to meds for all.
Federal Office for Central Services and Healthcare Procurement (BZgA): They handle the actual procurement process, ensuring transparency and value for money.

Who wins the most Pharmaceuticals contracts from the German government?

Some of the top companies taking home the schnitzels include:
Bayer: This German giant is a leader in aspirin, blood thinners, and cancer drugs.
Merck KGaA: Another German powerhouse, Merck brings its expertise in vaccines, diabetes treatments, and oncology.
Roche Holding: This Swiss heavyweight dominates cancer treatments and antibody drugs, making them a key player.

Tags -
Germany pharmaceutical tenders, Germany pharmaceuticals bids contracts, Germany pharmaceutical government tenders, Germany pharmaceutical global tenders, Germany free pharmaceutical tenders, Germany drugs tenders, Germany medicine tenders, Germany generic medicine tenders

4433 Live Notices for Germany Pharmaceuticals Tenders

Showing 1 to 20

Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Medicinal Product Name Xeomin(R), Atc M03Ax21
country Germany
posting date17 Jan 2025
deadline05 Jan 2027
Consolidated Analytical Platform (Kap) Including Laboratory Automation
country Germany
posting date17 Jan 2025
deadline01 Feb 2025
Open House Drug Discount Contracts Colecalciferol, Non Rx, Exclusively According To Annex 1 Am-Rl G-Ba Prescribable Products, Atc A11Cc05
country Germany
posting date17 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Telmisartan + Amlodipine, (Obg) Atc C09Db04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date17 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Progesterone Exclusively In The Dosage Form Vka, (Obo) Atc G03Da04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date17 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Elbasvir + Grazoprevir, (Obo) Atc J05Ap54 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date17 Jan 2025
deadline05 Jan 2027
Framework Agreement On Professional Skin Products (Vgst1-1-2024-0102)
country Germany
posting date17 Jan 2025
deadline31 Jan 2025
2025-03-Drug Development-Spectrometer-E23
country Germany
posting date17 Jan 2025
deadline30 Jan 2025
"Framework Agreement Of The Aurich Public Prosecutor'S Office For The Transfer Of Corpses To The Institute Of Forensic Medicine In Oldenburg"
country Germany
posting date17 Jan 2025
deadline31 Jan 2025
Nutrient Media Sterilizer + Maintenance + Accessories
country Germany
posting date17 Jan 2025
deadline04 Feb 2025
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Erythropoietin, Excluding Epoetin Alfa, (Obo) Atc B03Xa01 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Nitisinone, (Obo) Atc A16Ax04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Ustekinumab, (Obg) Atc L04Ac05 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Atovaquone, (Obg) Atc P01Ax06 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Pharmaceutical Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) Within The Framework Of Open-House Procedures
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Bempedoic Acid + Ezetimibe, (Obo) Atc C10Ba10 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegfilgrastim, (Obo) Atc L03Aa13 For The Period 01.03.2025 - 28.02.2026 (Plus Extension Option 1X12 Months)
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Intention To Conclude A Contract For The Supply Of Medical Aids (Here: Pg03 - Infusion And Drug Therapy (Excluding Parenteral Nutrition)) Including The Associated Services According To Section 127 Paragraph 1 Sgb V
country Germany
posting date16 Jan 2025
deadline31 Jan 2025
2025-03-Drug Development-Spectrometer-E23
country Germany
posting date16 Jan 2025
deadline30 Jan 2025
Pharmaceutical Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) Within The Framework Of Open-House Procedures
country Germany
posting date16 Jan 2025
deadline05 Jan 2027